Autologous blood transfusion is an endorsed blood conservation strategy that has become widely practiced in elective surgical procedures. Wereview ten years' experience in this arena, along with emerging strategies designed to continue to minimize allogeneic blood exposure but reduce the costs associated with autologous blood procurement. Weconclude that point-of-care autologous blood procurement (acute normovolemic hemodilution and intraoperative autologous blood salvage) can replace the predonation of autologous blood in surgical patients when transfusion medicine specialists, anesthesiologists, and surgeons develop a prospective, comprehensive approach to blood conservation. (Internal Medicine 37: 238-245, 1998) 
Introduction
Although the practice of autologous transfusion has existed for over 100 years, the last decade has seen explosive growth in the use of autologous blood, arising largely from concern over the risk of transfusion-transmitted diseases (1) . Although numerous professional organizations and federal agencies have endorsed autologous blood transfusion, advances in blood safety and the increased costs associated with blood conservation have caused health care organizations to reevaluate the role of autologous blood procurement in the surgical setting. This review is intended to summarize these developments and provide perspective on emerging autologous blood procurement strategies.
Preoperative Autologous Blood Donation
Someadvantages and disadvantages of preoperative autologous blood donation are summarized in Table 1 . Preoperative collection of autologous blood can, in selected patient subgroups, significantly reduce exposure to allogeneic blood.
Patients are considered candidates for preoperative autologous blood when scheduled for surgical procedures for which a blood transfusion is considered likely. For procedures that are unlikely to require transfusion (i.e. a maximal surgical blood ordering schedule does not suggest that blood be set up for cross-match (2) , preoperative blood collection has not been recommended.Over ten years experience with this technique has resulted in emerging issues that include re-evaluation of its safety, its efficacy, and its cost-effectiveness (3) .
Selection of patients Several recent guidelines have been published that provide recommendations for selecting patients suitable for autologous blood donation (4) (5) (6) (7) . Table 2 details guidelines recently published by the British Committee for standards in hematology (7) . The American Association of Blood Banks recommendations that patients with evidence of systemic infection or unstable angina be excluded; units from patients with positive viral markers may be collected with the approval of the patient is physician and the transfusion facility (8) . The first unit collected from a given patient during a 30-day period must have the same testing as allogeneic units for infectious disease markers (9) ; however, subsequent units need not be tested.
Supplemental iron is ideally prescribed before the first blood collection, in time to allow maximum iron intake. Iron restricted erythropoiesis is a limiting factor in successfully collecting multiple units of blood over a short interval (10). Oral iron maybe insufficient to maintain iron saturation in the setting of enhanced erythropoiesis (1 1). Autologous blood collection can be performed for patients who would not, under normal circumstances, be considered for allogeneic donation. With suitable volume modification and parental cooperation, pediatric patients can participate in preoperative collection programs ( 1 2) . Patients with significant cardiac disease are generally considered poor risks for autologous collection. Despite reports of safety in small numbersof patients scheduled for coronary artery bypass grafting who undergo autologous blood donation (13), the risks associated with autologous blood donation (14) in these patients are probably greater than current estimated risks of allogeneic transfusion (15).
Collecting blood from pregnant womenis rarely indicated (16) . In routine pregnancy and delivery or uncomplicated cesarean section, blood is needed so seldom that autologous collection is considered inappropriate. Potential candidates for autologous blood collection include womenwith alloantibodies to multiple or high-incidence antigens, or with placental previa or other conditions placing them at high risk for ante-or intrapartum hemorrhage ( 1 7 It is important to establish guidelines for the appropriate number of units to be collected. A sufficient number of units should be drawn, whenever possible, so that the patient can avoid exposure to allogeneic blood. Collection of units should be scheduled as far in advance of surgery as possible for liquid blood storage, in order to allow compensatory erythropoiesis ( 1 8-23 ) to prevent anemia ( Table 3 ). The efficacy ofautologous predonation is dependent on the degree to which the patient's erythropoiesis increases the production of red blood cells. Studies have shown that the endogenous erythropoietin response is suboptimal at the level of mild anemia produced under "standard" conditions of one blood unit (450 ± 45 ml) donated weekly. A computer model has predicted that if the erythropoietic response to autologous blood phlebotomyis not able to maintain the patient' s level of hematocrit during the donation interval, the predeposit of autologous blood may actually be harmful (24); this outcomewas confirmed in a recent study of patients undergoing hysterectomy (25), in which the authors demonstrated that preoperative autologous blood donation resulted in perioperative anemia and an increased likelihood of blood transfusion. The relationship between autologous blood ordering, and collection, and subsequent allogeneic blood transfusion in orthopaedic surgical patients has been examined (26 w^*\_^*^^^^^aŴ 2,000-"^^à""-^^^^A^1
,000-^^-b^^Ô permission, from Cohen JA, Brecher ME. procedures are wasted (17, 18, 25) . The additional costs associated with the collection of autologous units and the inherent "wastage" rate of these units, along with advances in the safety of allogeneic blood, now make the predonation of autologous blood poorly cost-effective (28, (35) (36) (37) . While autologous blood collections have become popular, the costs associated with collection are usually higher than for allogeneic blood. The cost-effectiveness of autologous blood programs has been questioned, because of the reduced risk of allogeneic blood transfusions and the pressure to reduce health-care costs (35). Somesuggestions that have been madeto makeautologous blood programs less costly include: abbreviate the donor interview for autologous collection; utilize only whole blood and discontinue component production; limit the use of frozen autologous blood; apply the same transfusion guidelines for autologous and allogeneic blood; and test only the first donated autologous blood unit for infectious disease markers.
A recently published mathematical model illustrates in Fig.  1 the relationship between anticipated surgical blood losses, the level of hematocrit that the physician maywant to maintain perioperatively, and the need for autologous blood donation for individual patients (3) . This model can predict the need for autologous blood predeposit in individual patients, and would be used as follows: (1) Measure the patient' s initial Hct. (2) Set the minimumtolerable Hct (transfusion trigger). This value should take into account individual patient characteristics such as age and medical status. (3) Apply these values to the graph shown in Fig. 1 to derive the estimated blood loss (EBL) necessary to reach this transfusion trigger. (4) Compare this
EBLto the standard EBLfor the particular surgical procedure, (a) If the EBL for the procedure (EBL-P) exceeds the EBL required for transfusion (EBL-T), then it is likely that a transfusion will be needed and that preoperative autologous blood donation (PAD) would be beneficial to this patient, (b) If the EBL-P is less than the EBL-T, then it is likely that transfusion will not be required and that PADis unnecessary.
Acute NormovolemicHemodilution
Acute normovolemic hemodilution (ANH) is a technique that comprises the removal of whole blood from a patient while restoring the circulating blood volume with a cellular fluid shortly before an anticipated significant surgical blood loss. Blood is collected in standard blood bags containing anticoagulant on a tilt-rocker with automatic cutoff via volumesensors.
The blood is then stored at room temperature, and rein fused in the operating roomafter major blood loss has ceased, or sooner if indicated. Simultaneous infusions ofcrystalloid (3 ml crystalloids: 1 ml blood withdrawn) and colloid (dextrans, starches, gelatin, albumin, 1 ml : 1 ml) have been recommended. Subsequent intraoperative fluid management is based on the usual surgical requirements. Blood units are rein fused in the reverse order of collection. The first unit collected, and therefore the last unit transfused, has the highest hematocrit and concentration of coagulation factors and platelets.
Effica cy
The chief benefit of hemodilution has been recognized to be the reduction of red cell losses whenwhole blood is shed perioperatively at lower hematocrit levels after ANHis complete (39). Mathematical modeling has suggested that severe hemodilution to preoperative hematocrit levels of less than 20%, accompanied by substantial blood losses, w7ould be required before the red cell volume "saved" by hemodilution became clinically important (40). A case study analysis of patients who had undergone "minimal" ANH(representing 15%ofpatients' blood volume) estimates that only 100 ml red cells (the equivalent of 1/2 unit of blood) is "saved" under these conditions (4 1 ). With moderate hemodilution, (target hematocrit levels of 28%), the "savings" becomes more substantial. exposure rates in previously-published series of elective surgery patients for which PADhas been regarded as the standard of care (27) (28) (29) . The benefit of ANHcan be illustrated in a mathematical model (Fig. 2) published recently. An adult with an estimated 5L blood volume and an initial hematocrit of40%, with surgical blood losses of up to 3,000 ml would result in a level of Minimum Hct (%) Figure 2 . The maximumallowable blood loss in a patient with a blood volume of 5,000 ml and an initial hematocrit level of 45% (the solid lines) or 40% (the dotted lines), with and without acute normovolemic hemodilution (ANH). From Goodnough LT et al, Hematology, In Press (Ref. 46) .
hematocrit that would remain >25 % postoperatively without an autologous blood intervention (46). This level of hematocrit is generally considered safe for patients with knownrisk factors (47). Patients undergoing radical prostatectomy procedures at our institution undergo surgical blood losses estimated by the anesthesiologist of 1,632 ± 75 1 ml. However, we have recently calculated that actual blood losses for surgical procedures are typically underestimated by a factor of two (48). Moreover, these procedures are accompanied by a 2% risk ofperioperative myocardial infarction (49). Note that in this model, the performance of ANHwith initial hematocrit levels of 40-45% would allow up to 2,500 to 3,500 ml surgical blood losses, yet the nadir level of hematocrit could be maintained >28%. The benefit of ANHin this model is to protect patients whohave substantial blood losses that cannot be predicted, and maintain perioperative levels ofhematocrit that minimize risks related to ischemia. Blood conservation strategies need to address both of these issues (50, 51).
In addition to an efficacy equivalent to PAD, ANHrepresents "point of care" autologous blood procurement and is therefore less costly than PAD. First, autologous blood units procured by ANHare re-transfused before leaving the operating room and require no inventory or testing costs. ANH therefore eliminates the possibility of an administrative error that could lead to an ABO-incompatibleblood transfusion and death, while PADdoes not eliminate this risk; the estimated risk of death from a hemolytic transfusion reaction (52) now approximates the risk of mortality from human immunodeficiency virus (HIV) or hepatitis infection from blood transfusion Microaggregate filters (40 microns) are most often used, as salvaged blood may contain tissue debris, small blood clots, or bone fragments. Cell washing devices can provide the equiva- semiautomated instruments compared to banked blood (57).
While the salvage of a minimumof one blood unit equivalent is possible for less expensive (with unwashed blood) methods, it is generally agreed that at least two blood unit equivalents need to be salvaged using the cell-saver (with washed blood) in order to achieve cost-effectiveness (57-59).
Postoperative Blood Salvage
Postoperative blood salvage denotes the collection of blood from surgical drains followed by rein fusion, with or without processing. In some programs, postoperative shed blood is collected into sterile canisters and rein fused without processing through a microaggregate filter. Blood collected is dilute, partially hemolyzed and defibrinated, and may contain high concentrations of cytokines. The concentration of fibrin degradation products can be very high, especially in shed mediastinal blood. Most programs set an upper limit on the volume of unprocessed blood that can be rein fused. If transfusion of blood has not begun within 6 hours of initiating the collection, the blood must be discarded. The evolution of cardiac surgery has been accompanied by a broad experience in conservation of blood postoperatively. Postoperative autologous blood salvage and rein fusion is practiced widely, but not uniformly. Prospective and controlled trials have disagreed over the efficacy of postoperative blood salvage in cardiac surgery patients; at least three such studies have demonstrated lack of efficacy (60-62) while at least two studies have shown benefit (63, 64). The disparity of results in these studies may be explained, in part, by differences in transfusion practices since the reports cited above incorporated criteria for blood transfusion into their protocols. Additionally, these studies were non-blinded, so that modification of physician transfusion practices mayhave been an uncredited intervention in these blood conservation studies.
In the post-operative orthopaedic surgical setting, a number of reports have similarly described the successful salvage and rein fusion of washed (65) and unwashed (66, 67) wound drainage frompatients undergoingarthroplasty. The volumeof rein fused drainage blood has been reported to be as muchas 3,000 cc, and average more than 1 , 100 cc in patients undergoing cementless knee replacement (67). The safety of rein fused unwashedorthopaedic wounddrainage has been controversial. Theoretical concerns have been expressed regarding infusion of potentially harmful materials in salvaged blood, including free hemoglobin, red cell stroma, marrowfat, toxic irritants, tissue or methacrylate debris, fibrin degradation products, and activated coagulation factors and complement. Although two small series have reported complications (68, 69), several larger studies have reported no serious adverse effects whendrainage was passed through a standard 40 Jim blood filter (66, 67, 70) . The potential for decreasing exposure to allogeneic blood among orthopaedic patients undergoing postoperative blood salvage, whether washed or unwashed, is greatest for cementless bilateral total knee replacement, revision hip or knee replacement, and long segment spinal fusion. As in the case of intraoperative salvage, blood loss mustbe sufficient to warrant the additional cost of processing technology (7 1). As in selection of patients whocan benefit from preoperative autologous blood donation and ANH,prospective identification of patients whocan benefit from intra and postoperative autologous blood salvage is possible if anticipated surgical blood losses and the perioperative "transfusion trigger" are taken into account ( Fig.   1 ).
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